nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CHRM3—ureter—cervical cancer	0.0993	0.232	CbGeAlD
Methotrimeprazine—CHRM3—exocrine gland—cervical cancer	0.0196	0.0458	CbGeAlD
Methotrimeprazine—CHRM5—epithelium—cervical cancer	0.0152	0.0356	CbGeAlD
Methotrimeprazine—ADRA1D—epithelium—cervical cancer	0.0136	0.0318	CbGeAlD
Methotrimeprazine—ADRA1B—renal system—cervical cancer	0.0129	0.0302	CbGeAlD
Methotrimeprazine—DRD5—female reproductive system—cervical cancer	0.0126	0.0295	CbGeAlD
Methotrimeprazine—DRD5—female gonad—cervical cancer	0.0115	0.0268	CbGeAlD
Methotrimeprazine—ADRA1D—female reproductive system—cervical cancer	0.0101	0.0237	CbGeAlD
Methotrimeprazine—CHRM3—renal system—cervical cancer	0.0079	0.0185	CbGeAlD
Methotrimeprazine—ADRA1A—epithelium—cervical cancer	0.00782	0.0183	CbGeAlD
Methotrimeprazine—HTR2C—female reproductive system—cervical cancer	0.00748	0.0175	CbGeAlD
Methotrimeprazine—ADRA2C—uterine cervix—cervical cancer	0.00739	0.0173	CbGeAlD
Methotrimeprazine—ADRA1A—renal system—cervical cancer	0.00725	0.017	CbGeAlD
Methotrimeprazine—CHRM1—female reproductive system—cervical cancer	0.00707	0.0165	CbGeAlD
Methotrimeprazine—ADRA2C—decidua—cervical cancer	0.00704	0.0165	CbGeAlD
Methotrimeprazine—ADRA2C—renal system—cervical cancer	0.00691	0.0162	CbGeAlD
Methotrimeprazine—ADRA2C—endometrium—cervical cancer	0.00668	0.0156	CbGeAlD
Methotrimeprazine—ADRA2C—mammalian vulva—cervical cancer	0.00646	0.0151	CbGeAlD
Methotrimeprazine—CHRM3—female reproductive system—cervical cancer	0.00633	0.0148	CbGeAlD
Methotrimeprazine—ADRA2C—uterus—cervical cancer	0.00616	0.0144	CbGeAlD
Methotrimeprazine—HRH1—epithelium—cervical cancer	0.00605	0.0142	CbGeAlD
Methotrimeprazine—HRH1—uterine cervix—cervical cancer	0.006	0.014	CbGeAlD
Methotrimeprazine—CYP1A2—renal system—cervical cancer	0.006	0.014	CbGeAlD
Methotrimeprazine—ADRA2A—uterine cervix—cervical cancer	0.00589	0.0138	CbGeAlD
Methotrimeprazine—CHRM3—female gonad—cervical cancer	0.00576	0.0135	CbGeAlD
Methotrimeprazine—HRH1—decidua—cervical cancer	0.00572	0.0134	CbGeAlD
Methotrimeprazine—ADRA2A—decidua—cervical cancer	0.00562	0.0131	CbGeAlD
Methotrimeprazine—HRH1—endometrium—cervical cancer	0.00543	0.0127	CbGeAlD
Methotrimeprazine—CYP2E1—renal system—cervical cancer	0.00539	0.0126	CbGeAlD
Methotrimeprazine—ADRA2A—endometrium—cervical cancer	0.00533	0.0125	CbGeAlD
Methotrimeprazine—HRH1—mammalian vulva—cervical cancer	0.00525	0.0123	CbGeAlD
Methotrimeprazine—ADRA2A—mammalian vulva—cervical cancer	0.00516	0.0121	CbGeAlD
Methotrimeprazine—HTR2A—epithelium—cervical cancer	0.00505	0.0118	CbGeAlD
Methotrimeprazine—ADRA2C—female gonad—cervical cancer	0.00504	0.0118	CbGeAlD
Methotrimeprazine—ADRA2C—vagina—cervical cancer	0.005	0.0117	CbGeAlD
Methotrimeprazine—ADRA2A—uterus—cervical cancer	0.00491	0.0115	CbGeAlD
Methotrimeprazine—HTR2A—renal system—cervical cancer	0.00469	0.011	CbGeAlD
Methotrimeprazine—HRH1—female reproductive system—cervical cancer	0.0045	0.0105	CbGeAlD
Methotrimeprazine—ADRA2A—female reproductive system—cervical cancer	0.00442	0.0103	CbGeAlD
Methotrimeprazine—CYP2E1—female reproductive system—cervical cancer	0.00432	0.0101	CbGeAlD
Methotrimeprazine—CYP2D6—renal system—cervical cancer	0.00427	0.00999	CbGeAlD
Methotrimeprazine—HRH1—female gonad—cervical cancer	0.00409	0.00957	CbGeAlD
Methotrimeprazine—HRH1—vagina—cervical cancer	0.00407	0.00951	CbGeAlD
Methotrimeprazine—ADRA2A—female gonad—cervical cancer	0.00402	0.0094	CbGeAlD
Methotrimeprazine—ADRA2A—vagina—cervical cancer	0.00399	0.00934	CbGeAlD
Methotrimeprazine—HTR2A—female reproductive system—cervical cancer	0.00375	0.00878	CbGeAlD
Methotrimeprazine—CYP2D6—female reproductive system—cervical cancer	0.00342	0.008	CbGeAlD
Methotrimeprazine—HTR2A—vagina—cervical cancer	0.0034	0.00794	CbGeAlD
Methotrimeprazine—ADRA2C—lymph node—cervical cancer	0.00324	0.00757	CbGeAlD
Methotrimeprazine—CYP2D6—female gonad—cervical cancer	0.00311	0.00728	CbGeAlD
Methotrimeprazine—HRH1—lymph node—cervical cancer	0.00263	0.00615	CbGeAlD
Methotrimeprazine—ADRA2A—lymph node—cervical cancer	0.00258	0.00604	CbGeAlD
Methotrimeprazine—CHRM2—Signaling Pathways—AKAP13—cervical cancer	0.000247	0.000431	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000246	0.00043	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000243	0.000425	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000239	0.000418	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000229	0.0004	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000228	0.000398	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—NOTCH2—cervical cancer	0.000225	0.000393	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TERT—cervical cancer	0.000222	0.000387	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000221	0.000385	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000217	0.000379	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000217	0.000378	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—WNT5A—cervical cancer	0.000216	0.000377	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—WNT5A—cervical cancer	0.000215	0.000376	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—NOTCH2—cervical cancer	0.000215	0.000376	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—WNT5A—cervical cancer	0.000213	0.000372	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000213	0.000371	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000205	0.000358	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—FGFR3—cervical cancer	0.000204	0.000355	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000202	0.000353	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.000202	0.000353	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000198	0.000345	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CA9—cervical cancer	0.000192	0.000335	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—NOTCH1—cervical cancer	0.000191	0.000334	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HES1—cervical cancer	0.000187	0.000326	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HES1—cervical cancer	0.000184	0.000322	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000183	0.000319	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HES1—cervical cancer	0.000176	0.000308	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000175	0.000306	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000171	0.000298	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling by GPCR—EGFR—cervical cancer	0.00017	0.000297	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HES1—cervical cancer	0.000168	0.000294	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000168	0.000293	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000166	0.00029	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HES1—cervical cancer	0.000166	0.00029	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TERT—cervical cancer	0.000164	0.000286	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CA9—cervical cancer	0.000162	0.000284	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TERT—cervical cancer	0.000161	0.000282	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000155	0.00027	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TERT—cervical cancer	0.000155	0.00027	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000152	0.000266	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.000152	0.000266	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	0.000152	0.000265	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NOTCH2—cervical cancer	0.000151	0.000264	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.00015	0.000262	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.00015	0.000262	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	0.00015	0.000261	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000149	0.000261	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—FGFR3—cervical cancer	0.000148	0.000259	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Hemostasis—TP53—cervical cancer	0.000147	0.000257	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TERT—cervical cancer	0.000147	0.000257	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000147	0.000257	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000145	0.000254	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TERT—cervical cancer	0.000145	0.000254	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000144	0.000251	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MTOR—cervical cancer	0.000143	0.00025	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—FGFR3—cervical cancer	0.000142	0.000248	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—NOTCH1—cervical cancer	0.000141	0.000246	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.00014	0.000244	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	0.000139	0.000243	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000139	0.000242	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000138	0.000241	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—TP53—cervical cancer	0.000138	0.000241	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—FGFR3—cervical cancer	0.000135	0.000236	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	0.000133	0.000233	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000133	0.000233	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	0.000133	0.000233	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—CASP3—cervical cancer	0.000132	0.00023	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000131	0.000229	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—MTHFR—cervical cancer	0.00013	0.000227	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HES1—cervical cancer	0.000127	0.000222	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	0.000127	0.000222	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—CTNNB1—cervical cancer	0.000127	0.000222	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000126	0.00022	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling by GPCR—EGFR—cervical cancer	0.000126	0.000219	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	0.000125	0.000219	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000125	0.000219	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000125	0.000218	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HES1—cervical cancer	0.000125	0.000218	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HES1—cervical cancer	0.000124	0.000217	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—EGFR—cervical cancer	0.000124	0.000217	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HES1—cervical cancer	0.000124	0.000216	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HES1—cervical cancer	0.000123	0.000214	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000123	0.000214	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000122	0.000214	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000121	0.000211	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.00012	0.00021	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000119	0.000209	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—EGFR—cervical cancer	0.000119	0.000207	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000116	0.000202	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000114	0.000199	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—EGFR—cervical cancer	0.000113	0.000198	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000113	0.000198	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000113	0.000197	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—TP53—cervical cancer	0.000112	0.000195	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	0.000112	0.000195	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000112	0.000195	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TERT—cervical cancer	0.000111	0.000194	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	0.000111	0.000193	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—STAT3—cervical cancer	0.000111	0.000193	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—MTHFR—cervical cancer	0.00011	0.000192	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000109	0.000191	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TERT—cervical cancer	0.000109	0.000191	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TERT—cervical cancer	0.000109	0.00019	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000109	0.00019	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TERT—cervical cancer	0.000109	0.00019	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TERT—cervical cancer	0.000107	0.000188	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TERT—cervical cancer	0.000107	0.000187	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MTOR—cervical cancer	0.000106	0.000185	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000106	0.000185	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MTOR—cervical cancer	0.000104	0.000182	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	0.000104	0.000182	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000102	0.000178	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.000101	0.000176	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—EGFR—cervical cancer	0.000101	0.000176	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.0001	0.000175	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—FGFR3—cervical cancer	0.0001	0.000175	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—FGFR3—cervical cancer	9.99e-05	0.000175	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MTOR—cervical cancer	9.98e-05	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—FGFR3—cervical cancer	9.96e-05	0.000174	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TERT—cervical cancer	9.96e-05	0.000174	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	9.86e-05	0.000172	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	9.84e-05	0.000172	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CASP3—cervical cancer	9.72e-05	0.00017	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	9.68e-05	0.000169	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CASP3—cervical cancer	9.59e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	9.59e-05	0.000167	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MTOR—cervical cancer	9.51e-05	0.000166	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	9.43e-05	0.000165	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	9.41e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	9.41e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MTOR—cervical cancer	9.39e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MTOR—cervical cancer	9.39e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	9.38e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CTNNB1—cervical cancer	9.37e-05	0.000164	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	9.35e-05	0.000163	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	9.26e-05	0.000162	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	9.26e-05	0.000162	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	9.24e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	9.24e-05	0.000161	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CASP3—cervical cancer	9.18e-05	0.00016	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	9.14e-05	0.00016	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	8.85e-05	0.000155	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CASP3—cervical cancer	8.75e-05	0.000153	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CASP3—cervical cancer	8.63e-05	0.000151	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CASP3—cervical cancer	8.63e-05	0.000151	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	8.58e-05	0.00015	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—EGFR—cervical cancer	8.54e-05	0.000149	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MTOR—cervical cancer	8.48e-05	0.000148	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—cervical cancer	8.44e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	8.44e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	8.4e-05	0.000147	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—EGFR—cervical cancer	8.39e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—EGFR—cervical cancer	8.36e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—EGFR—cervical cancer	8.33e-05	0.000146	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	8.32e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CTNNB1—cervical cancer	8.32e-05	0.000145	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	8.25e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	8.23e-05	0.000144	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—STAT3—cervical cancer	8.17e-05	0.000143	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MTOR—cervical cancer	8.14e-05	0.000142	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—STAT3—cervical cancer	8.06e-05	0.000141	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MTOR—cervical cancer	7.92e-05	0.000138	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CASP3—cervical cancer	7.8e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	7.79e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MTHFR—cervical cancer	7.78e-05	0.000136	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—STAT3—cervical cancer	7.72e-05	0.000135	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	7.65e-05	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	7.51e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CASP3—cervical cancer	7.49e-05	0.000131	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—EGFR—cervical cancer	7.42e-05	0.00013	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—STAT3—cervical cancer	7.35e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—EGFR—cervical cancer	7.32e-05	0.000128	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CASP3—cervical cancer	7.28e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—STAT3—cervical cancer	7.25e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—STAT3—cervical cancer	7.25e-05	0.000127	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	7.22e-05	0.000126	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MTOR—cervical cancer	7.18e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	7.17e-05	0.000125	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MTOR—cervical cancer	7.07e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MTOR—cervical cancer	7.05e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MTOR—cervical cancer	7.03e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	7.02e-05	0.000123	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—EGFR—cervical cancer	7.01e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MTOR—cervical cancer	7.01e-05	0.000122	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MTOR—cervical cancer	6.94e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	6.92e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	6.91e-05	0.000121	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EGFR—cervical cancer	6.68e-05	0.000117	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CASP3—cervical cancer	6.61e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—cervical cancer	6.59e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EGFR—cervical cancer	6.59e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EGFR—cervical cancer	6.59e-05	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—STAT3—cervical cancer	6.55e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CASP3—cervical cancer	6.5e-05	0.000114	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CASP3—cervical cancer	6.49e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CASP3—cervical cancer	6.47e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CASP3—cervical cancer	6.45e-05	0.000113	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	6.43e-05	0.000112	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CASP3—cervical cancer	6.38e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	6.37e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	6.37e-05	0.000111	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—STAT3—cervical cancer	6.29e-05	0.00011	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	6.27e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	6.25e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	6.23e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—cervical cancer	6.23e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	6.21e-05	0.000109	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	6.15e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—cervical cancer	6.15e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	6.14e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—STAT3—cervical cancer	6.12e-05	0.000107	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	6.02e-05	0.000105	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EGFR—cervical cancer	5.95e-05	0.000104	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	5.91e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—cervical cancer	5.89e-05	0.000103	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EGFR—cervical cancer	5.72e-05	9.98e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	5.7e-05	9.96e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—cervical cancer	5.61e-05	9.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EGFR—cervical cancer	5.56e-05	9.71e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—STAT3—cervical cancer	5.55e-05	9.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—cervical cancer	5.54e-05	9.67e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—cervical cancer	5.54e-05	9.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	5.47e-05	9.56e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—STAT3—cervical cancer	5.46e-05	9.54e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—STAT3—cervical cancer	5.45e-05	9.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—STAT3—cervical cancer	5.43e-05	9.49e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—STAT3—cervical cancer	5.42e-05	9.46e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—STAT3—cervical cancer	5.36e-05	9.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	5.35e-05	9.34e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EGFR—cervical cancer	5.05e-05	8.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—cervical cancer	5e-05	8.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	4.97e-05	8.68e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EGFR—cervical cancer	4.96e-05	8.67e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EGFR—cervical cancer	4.95e-05	8.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EGFR—cervical cancer	4.94e-05	8.62e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EGFR—cervical cancer	4.92e-05	8.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EGFR—cervical cancer	4.87e-05	8.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	4.86e-05	8.49e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—cervical cancer	4.8e-05	8.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—cervical cancer	4.67e-05	8.15e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—cervical cancer	4.59e-05	8.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	4.52e-05	7.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—cervical cancer	4.24e-05	7.4e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—cervical cancer	4.17e-05	7.28e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—cervical cancer	4.16e-05	7.26e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—cervical cancer	4.15e-05	7.24e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—cervical cancer	4.13e-05	7.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—cervical cancer	4.09e-05	7.15e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—cervical cancer	4.08e-05	7.13e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—cervical cancer	3.79e-05	6.62e-05	CbGpPWpGaD
